483 Haupt Pharma Wolfratshausen Apr 2016

483 Haupt Pharma Wolfratshausen Apr 2016

David Anderson FDA, Meisha Sampson FDA, Meisha Waters FDA$119.00 - Available Now

FDA investigators audited the Haupt Pharma Wolfratshausen - Wolfratshausen, Germany facility and issued 9 inspectional observations (via FDA 483) on 09 Apr 2016.

Product details

  • Category: Human Drugs
  • Number of Observations: 9
  • Inspection end: 09 Apr 2016
  • Location: Wolfratshausen, Germany
  • FEI: 3000310230
Add To Cart